In an integrated audit of internal control over financial reporting and the financial statements, the auditor also may use this work to obtain evidence supporting the auditor's assessment of control risk for purposes of the audit of the financial statements.
A new development in uveitis treatment during the past few years is the increased use of tumor necrosis alpha (TNF-Î±) inhibitors, specifically infliximab (Remicade, Janssen Biotech Inc.) and adalimumab (Humira, Abbott Laboratories).
HIV Medications. Several different classes of medications for HIV are available. These classes are divided into seven different groups and include NRTIs, NNRTIs, NtRTIs, protease inhibitors, entry inhibitors, integrase inhibitors, and combination medications. In most cases, people with HIV or AIDS use medications from several of these classes.